Cadilla Healthcare hit a new 52-week low at Rs.291.90 but after that, it has bounced back into the green and it actually went up 2.3% to Rs.310.90.

The market reacted negatively to the news that the USFDA inspected the company’s formulations manufacturing facility located at Moraiya, Ahmedabad from 22nd April 2019 to 3’d May 2019.

The inspection concluded with 14 observations. There were no repeat observations or Data Integrity (Di) related observations.